Welcome Guest
Home > Clinical Breast Cancer > Volume 5 |  Issue 4

Table of Contents

Volume 5 |  Issue 4

Publication Date: October 2004
  • Abstract Abstract
  • Full Text No Access
  • Full Text Pay-Per View
  • Full Text Full Text
  • Add to Cart Add to Cart


Comprehensive Review
Page Number of this Article in the Print Version
260-268		 Breast Cancer Surveillance in Women with Hereditary Risk Due to BRCA1 or BRCA2 Mutations
Mark Robson
  • Abstract
  • No Access
  • Add to Cart
Commentary
Page Number of this Article in the Print Version
269-271		 Screening of Women with Hereditary Risk of Breast Cancer
Christiane K. Kuhl
  • Abstract
  • No Access
  • Add to Cart
Original Contributions
Page Number of this Article in the Print Version
273-278		 Survival Benefit with Capecitabine/Docetaxel Versus Docetaxel Alone: Analysis of Therapy in a Randomized Phase III Trial
David Miles, Svetislava Vukelja, Vladimir Moiseyenko, Guadalupe Cervantes, Louis Mauriac, Guy Van Hazel, Wing-Yiu Liu, Jean-Pierre Ayoub, Joyce A. O’Shaughnessy
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
279-284		 Internal Mammary Node Drainage and its Role in Sentinel Lymph Node Biopsy: The Initial ALMANAC Experience
Robert E. Mansel, Amit Goyal, Robert G. Newcombe, on behalf of the ALMANAC Trialists Group
  • Abstract
  • No Access
  • Add to Cart
Commentary
Page Number of this Article in the Print Version
285-286		 “Ultrastaging” of Breast Cancer in the Sentinel Lymph Node Era
James Jakub, Solange Pendas, Gray Swor, Mary Gardner, Rosemary Giuliano, Douglas Reintgen
  • Abstract
  • No Access
  • Add to Cart
Original Contributions
Page Number of this Article in the Print Version
287-292		 Final Results of a Phase II Clinical Trial of Weekly Docetaxel in Combination with Capecitabine in Anthracycline-Pretreated Metastatic Breast Cancer
John R. Mackey, Katia S. Tonkin, Sheryl L. Koski, Andrew G. Scarfe, Michael G. B. Smylie, Anil A. Joy, Heather-Jane Au, Dianne M. Bodnar, Denis Soulieres, Stephanie W. Smith
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
293-298		 Effect of Cardiac Dysfunction on Treatment Outcomes in Women Receiving Trastuzumab for HER2-Overexpressing Metastatic Breast Cancer
Debu Tripathy, Andrew Seidman, Deborah Keefe, Clifford Hudis, Virginia Paton, Grazyna Lieberman
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
299-302		 Ductal Lavage Using Medically Aseptic Technique in Women at High Risk for Breast Cancer
Darius S. Francescatti, Larry Kluskens, Lisa Shah
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
303-307		 Neoadjuvant FEC 100 for Operable Breast Cancer: Eight-Year Experience at Centre Jean Perrin
Marie-Ange Mouret-Reynier, Catherine J. Abrial, Jean-Pierre Ferrière, Sophie Amat, Hervé D. Curé, Fabrice G. Kwiatkowski, Viviane A. Feillel, Guillaume Lebouëdec, Frédérique M. Penault-Llorca, Philippe J. M. Chollet
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
308-312		 Selection Criteria for Accelerated Partial-Breast Irradiation: Impact on Applicability
Melanie C. Smitt
  • Abstract
  • No Access
  • Add to Cart
Work in Progress
Page Number of this Article in the Print Version
313-316		 A Method for Making Estimates of the Benefit of the Late Use of Letrozole in Patients Completing 5 Years of Tamoxifen
Peter M. Ravdin, Gregory J. Davis
  • Abstract
  • No Access
  • Add to Cart
Case Report
Page Number of this Article in the Print Version
317-319		 Paclitaxel Chemotherapy in a Pregnant Patient with Bilateral Breast Cancer
Ana M. Gonzalez-Angulo, Ronald S. Walters, Robert J. Carpenter, Jr, Merrick I. Ross, George H. Perkins, Karin Gwyn, Richard L. Theriault
  • Abstract
  • No Access
  • Add to Cart